CVS Health Corp. (CVS)

75.36
NYSE : Retail Trade
Prev Close 74.48
Day Low/High 75.00 / 75.75
52 Wk Low/High 51.72 / 78.06
Avg Volume 6.88M
Exchange NYSE
Shares Outstanding 1.30B
Market Cap 96.90B
EPS -0.60
P/E Ratio 22.23
Div & Yield 2.00 (2.67%)

Latest News

Jim Cramer: Stop Speculating on Deals

Jim Cramer: Stop Speculating on Deals

I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.

CVS Hit One Out of the Park, Here's My Plan

CVS Hit One Out of the Park, Here's My Plan

I like the name, and I like the progress that CVS is making. This stock can go higher.

CVS Health Continues to Improve With Stronger Charts and Fundamentals, Too

CVS Health Continues to Improve With Stronger Charts and Fundamentals, Too

Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.

The Week Ahead: Earnings Season Is Far From Over

The Week Ahead: Earnings Season Is Far From Over

Disney, Qualcomm and Square are among 75 key reports we are watching.

It's Settled: CVS Health Is Headed Up to $80

It's Settled: CVS Health Is Headed Up to $80

Charts and indicators agree with Jim Cramer's bullish year-end call.

Jim Cramer: The Market Is Lapping Up These Stocks

Jim Cramer: The Market Is Lapping Up These Stocks

There are plenty of senior growth companies that can still move higher.

Real Money Post-Industrial Average Continues to Outpace Major Indices

Real Money Post-Industrial Average Continues to Outpace Major Indices

RMPIA is up 20.9% in the first nine months of 2019.

Jim Cramer: Watch for Stocks Reporting 'Not as Bad as Feared' Numbers

Jim Cramer: Watch for Stocks Reporting 'Not as Bad as Feared' Numbers

When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.

Jim Cramer: Here's Why the Market's So Feckless and Reactive

Jim Cramer: Here's Why the Market's So Feckless and Reactive

So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.

With CVS, Bulls Still Have Their Work Cut Out for Them

With CVS, Bulls Still Have Their Work Cut Out for Them

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape

CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape

Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.

CVS Health Continues to Move Higher - New Stop Recommendation

CVS Health Continues to Move Higher - New Stop Recommendation

CVS continues to move in the right direction for the bulls.

The Charts of CVS Health Are Coming Out of Rehab

The Charts of CVS Health Are Coming Out of Rehab

Let's check out the charts.

Real Money Post-Industrial Average Holds Own in Turbulent August

Real Money Post-Industrial Average Holds Own in Turbulent August

Gains in Amgen, CVS, and others helped offset declines in other stocks, as the RMPIA rose over the last two months to 0.6%, handily beating all the major domestic stock market averages.

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

Agency has the authority to carve out an exception to existing laws.

Uber Gets an Early Lyft

Uber Gets an Early Lyft

LYFT's earnings beat appears to be giving hope to Uber investors in advance of its own report later Thursday, but the two rivals have key strengths to watch, such as Lyft's U.S. focus and Uber's move on food delivery.

Jim Cramer: In America, Lower Rates Are Nirvana for the Consumer and Stocks

Jim Cramer: In America, Lower Rates Are Nirvana for the Consumer and Stocks

Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.

China's Yuan Threat, Disney Volatility: Market Recon

China's Yuan Threat, Disney Volatility: Market Recon

The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.

CBD Is Flexing on the Marijuana Industry

CBD Is Flexing on the Marijuana Industry

Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.

European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco

European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco

This matters: Why the sudden 'weakness' across European debt markets?

Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now

Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now

I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.

How 'Window Dressing' Can Hide the Losers

How 'Window Dressing' Can Hide the Losers

By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.

Future Looks Healthy for CVS

Future Looks Healthy for CVS

CVS and Walgreens Boots Alliance make for good buys.

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

3 Managed Care Providers Are Finally Looking Promising on the Charts

3 Managed Care Providers Are Finally Looking Promising on the Charts

A look at the charts and indicators of three big names in the sector .

Make Big Money: Think Like an Insider

Make Big Money: Think Like an Insider

Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.